Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed CFO
Quarterly results
Credit agrmnt [a]
Acq. announced
Director departure
CC transcript
Actavis, Inc. (ACT) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2012 PRN Watson Receives Approval from European Commission for Pending Actavis Acquisition
09/27/2012 PRN Watson Prices $3.9 Billion of Senior Unsecured Notes
08/27/2012 PRN Watson to Present at the Morgan Stanley 2012 Global Healthcare Conference
08/23/2012 PRN Watson's Generic Lidoderm(R) Receives FDA Approval
08/20/2012 PRN Watson Launches Generic Xopenex®
05/18/2012 PRN Watson to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
05/04/2012 PRN Watson to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
04/30/2012 PRN Watson First Quarter 2012 Non-GAAP EPS Increases 84% to $1.64; Net Revenue Increases 74% to $1.5 Billion
04/27/2012 PRN Watson adquiere Actavis Group por 4.250 millones de euros
04/03/2012 PRN Watson Confirms Favorable District Court Ruling in Generic Sanctura XR® Patent Suit
03/20/2012 PRN Watson's Generic BONIVA® 150mg Receives FDA Approval
03/12/2012 PRN Watson Announces Initiation of Esmya(R) U.S. Phase 3 Clinical Trial
03/02/2012 PRN Watson Launches Generic PROMETRIUM(R)
02/27/2012 PRN Watson Receives Complete Response Letter from FDA for Progesterone Vaginal Gel 8%
02/03/2012 PRN Watson Provides Update on Generic Lidoderm® Application
01/30/2012 PRN Watson Announces New Jersey-Based Global R&D Technology Center
01/24/2012 PRN Watson Acquires Ascent Pharmahealth for AU$375 Million
01/18/2012 PRN Watson Launches Generic Yaz(R)
01/12/2012 PRN Watson to Host Investor Meeting January 24 in New York City
12/28/2011 PRN Watson to Present at the 30th Annual J.P. Morgan Healthcare Conference
12/08/2011 PRN Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder
11/30/2011 PRN Watson Launches Generic LIPITOR®
11/21/2011 PRN Watson to Present at the 2011 Piper Jaffray Health Care Conference
11/16/2011 PRN Watson Wins Kentucky Drug Pricing Litigation
10/28/2011 PRN Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX®
10/17/2011 PRN Watson Confirms Atelvia(TM) Patent Challenge
10/14/2011 PRN Watson Confirms Daytrana(R) Patent Challenge
10/08/2011 PRN Watson Provides Update on District Court Order Concerning Generic Version of LOVENOX®
10/07/2011 PRN Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R)
10/07/2011 PRN Watson Confirms EMBEDA(R) Patent Challenge
09/22/2011 PRN Watson to Present at the Jefferies 2011 Global Healthcare Conference
09/19/2011 PRN Watson Pharmaceuticals Announces Approval of Amphastar's Generic LOVENOX(R)
08/11/2011 PRN Watson's Anda Distribution to Build 234,000 sq ft Pharmaceutical Warehouse and Distribution Facility in Olive Branch, DeSoto County, MS
07/22/2011 PRN Watson Confirms JALYN™ Patent Challenge
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy